Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,364.00
(
0.50%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.45
(
-0.41%
)
Bitcoin
71,800.47
(
0.94%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 234243

Thursday, 06/30/2022 10:28:17 AM

Thursday, June 30, 2022 10:28:17 AM

Post# of 257375
FDA places clinical hold on SNY’s Tolebrutinib trials:

https://www.sanofi.com/en/media-room/press-releases/2022/2022-06-30-05-30-00-2471767

Tolebrutinib is the BTK inhibitor SNY picked up in the $3.4B 2020 buyout of Principia Biopharma (#msg-157669162).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today